arrow
B

Bengt Jönsson

European Academy of Cancer Sciences
H指数:84
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Developing evidence-based, cost-effective P4 cancer medicine for driving innovation in prevention, therapeutics, patient care and reducing healthcare inequalities

开发基于证据、具有成本效益的P4癌症医学,以推动在预防、治疗、患者护理方面的创新,并减少医疗不平等。

2025-12-150
OAAI
Strategies to decrease inequalities in cancer therapeutics, care and preventionProceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023

减少癌症治疗,护理和预防不平等现象的策略在2023年2月23至24日梵蒂冈城由宗座科学院和欧洲癌症科学院组织的会议上进行

2024-01-2211
OA
An experience- and preference-based EQ-5D-3L value set derived using 18 months of longitudinal data in patients who sustained a fracture: results from the ICUROS

使用持续骨折患者18个月的纵向数据得出的基于经验和偏好的EQ-5D-3L值集: ICUROS的结果

2022-12-100
OAAI
The Porto European Cancer Research Summit 2021

波尔图欧洲癌症研究峰会2021

2021-09-136
OA
Towards a cancer mission in Horizon Europe: recommendations
2020-08-0431
OAAI
Quality of life after hip, vertebral, and distal forearm fragility fractures measured using the EQ-5D-3L, EQ-VAS, and time-trade-off: results from the ICUROS

使用EQ-5D-3L,eq-vas和时间权衡测量的髋部,椎骨和前臂远端脆性骨折后的生活质量: ICUROS的结果

2017-12-1234
PREAI